Listing 1 - 9 of 9 |
Sort by
|
Choose an application
Over the years, there has been increasing interest into the public health impact of cannabis use, especially by young adults. This follows the evidence of a growing prevalence of regular cannabis use worldwide, with approximately 200 million users. Recreational cannabis use, especially a frequent use of products with high levels of its main psychoactive ingredient delta-9-tetrahydrocannabinol (Δ 9-THC), can cause dependence and have transient and long-lasting detrimental mental health effects, also negatively impacting cognitive processing and brain function and metabolism. In regular users, the development of tolerance to some of the effects of cannabis, especially the pleasurable ones, may lead to progressively heavier use in order to obtain the same effects in terms of their intensity, with higher health risks. However, the Cannabis Sativa plant contains different chemicals with different potential effects. In this regard, cannabidiol has gained interest because of its potential therapeutic properties, in line with evidence that CBD and Δ9-THC may exhibit opposite effects at the cannabinoid receptor type 1 (CB1), Δ9-THC being a partial agonist and CBD an antagonist/inverse agonist. Different cannabinoids may modulate human brain function and behavior in different ways, with different risk–benefit profiles.
Medicine --- Neurosciences --- delta-9-tetrahydrocannabinol --- placebo --- cannabis-associated psychosis --- schizophrenia --- BDNF --- CB1 --- CB2 --- episodic memory --- exercise --- African American --- black --- older adult --- marijuana use --- cannabis use disorder --- cue reactivity --- craving --- inhibitory control --- frontal alpha asymmetry --- EEG --- cannabinoids --- cannabis use --- psychotic disorder --- genetics --- age of onset --- clinical high risk --- cannabis --- memory --- functional magnetic resonance imaging --- THC --- systematic review --- gyrification --- surface area --- cortical surface structure --- aerobic fitness --- gender --- endocannabinoid system --- executive functions --- problematic cannabis use --- triple network --- EEG functional connectivity --- eLORETA --- resting state --- Delta-9-tetrahydrocannabinol --- dronabinol --- marijuana --- randomized controlled trial --- opioids --- traumatic injury --- alcohol --- adolescents --- fMRI --- interoception --- negative reinforcement --- migraine: chronic pain --- triptans --- disability --- n/a
Choose an application
Over the years, there has been increasing interest into the public health impact of cannabis use, especially by young adults. This follows the evidence of a growing prevalence of regular cannabis use worldwide, with approximately 200 million users. Recreational cannabis use, especially a frequent use of products with high levels of its main psychoactive ingredient delta-9-tetrahydrocannabinol (Δ 9-THC), can cause dependence and have transient and long-lasting detrimental mental health effects, also negatively impacting cognitive processing and brain function and metabolism. In regular users, the development of tolerance to some of the effects of cannabis, especially the pleasurable ones, may lead to progressively heavier use in order to obtain the same effects in terms of their intensity, with higher health risks. However, the Cannabis Sativa plant contains different chemicals with different potential effects. In this regard, cannabidiol has gained interest because of its potential therapeutic properties, in line with evidence that CBD and Δ9-THC may exhibit opposite effects at the cannabinoid receptor type 1 (CB1), Δ9-THC being a partial agonist and CBD an antagonist/inverse agonist. Different cannabinoids may modulate human brain function and behavior in different ways, with different risk–benefit profiles.
delta-9-tetrahydrocannabinol --- placebo --- cannabis-associated psychosis --- schizophrenia --- BDNF --- CB1 --- CB2 --- episodic memory --- exercise --- African American --- black --- older adult --- marijuana use --- cannabis use disorder --- cue reactivity --- craving --- inhibitory control --- frontal alpha asymmetry --- EEG --- cannabinoids --- cannabis use --- psychotic disorder --- genetics --- age of onset --- clinical high risk --- cannabis --- memory --- functional magnetic resonance imaging --- THC --- systematic review --- gyrification --- surface area --- cortical surface structure --- aerobic fitness --- gender --- endocannabinoid system --- executive functions --- problematic cannabis use --- triple network --- EEG functional connectivity --- eLORETA --- resting state --- Delta-9-tetrahydrocannabinol --- dronabinol --- marijuana --- randomized controlled trial --- opioids --- traumatic injury --- alcohol --- adolescents --- fMRI --- interoception --- negative reinforcement --- migraine: chronic pain --- triptans --- disability --- n/a
Choose an application
Over the years, there has been increasing interest into the public health impact of cannabis use, especially by young adults. This follows the evidence of a growing prevalence of regular cannabis use worldwide, with approximately 200 million users. Recreational cannabis use, especially a frequent use of products with high levels of its main psychoactive ingredient delta-9-tetrahydrocannabinol (Δ 9-THC), can cause dependence and have transient and long-lasting detrimental mental health effects, also negatively impacting cognitive processing and brain function and metabolism. In regular users, the development of tolerance to some of the effects of cannabis, especially the pleasurable ones, may lead to progressively heavier use in order to obtain the same effects in terms of their intensity, with higher health risks. However, the Cannabis Sativa plant contains different chemicals with different potential effects. In this regard, cannabidiol has gained interest because of its potential therapeutic properties, in line with evidence that CBD and Δ9-THC may exhibit opposite effects at the cannabinoid receptor type 1 (CB1), Δ9-THC being a partial agonist and CBD an antagonist/inverse agonist. Different cannabinoids may modulate human brain function and behavior in different ways, with different risk–benefit profiles.
Medicine --- Neurosciences --- delta-9-tetrahydrocannabinol --- placebo --- cannabis-associated psychosis --- schizophrenia --- BDNF --- CB1 --- CB2 --- episodic memory --- exercise --- African American --- black --- older adult --- marijuana use --- cannabis use disorder --- cue reactivity --- craving --- inhibitory control --- frontal alpha asymmetry --- EEG --- cannabinoids --- cannabis use --- psychotic disorder --- genetics --- age of onset --- clinical high risk --- cannabis --- memory --- functional magnetic resonance imaging --- THC --- systematic review --- gyrification --- surface area --- cortical surface structure --- aerobic fitness --- gender --- endocannabinoid system --- executive functions --- problematic cannabis use --- triple network --- EEG functional connectivity --- eLORETA --- resting state --- Delta-9-tetrahydrocannabinol --- dronabinol --- marijuana --- randomized controlled trial --- opioids --- traumatic injury --- alcohol --- adolescents --- fMRI --- interoception --- negative reinforcement --- migraine: chronic pain --- triptans --- disability
Choose an application
This book includes a compilation of papers published in 2020 and 2021 focused on dual disorders, which are found in significant and growing numbers in both substance addiction and mental health clinics. These contributions assume a broad perspective ranging from exposure to genetic and neurobiological elements to factors such as personality and quality of life. In all cases, these papers aimed to be transferred to and to benefit clinical practice.
Medicine --- Mental health services --- temperament --- character --- personality --- substance use disorder --- schizophrenia --- dual schizophrenia --- psychiatric symptoms --- global functioning --- dual disorders --- addiction --- sleep --- risk factors --- Substance-use disorder --- substance-related disorders --- alcohol use disorder --- post-traumatic stress disorder --- childhood trauma --- psychiatric disorders --- rehabilitation centers --- impulsive behavior --- addictive disorders --- flaws --- conceptual framework --- concurrent disorder --- co-occurring disorder --- dual diagnosis --- dual pathology --- addiction comorbidity --- comorbid substance abuse --- comorbid illicit use --- comorbid addiction --- comorbid mental illness --- coexisting mental illness --- psychological trauma --- posttraumatic stress disorder --- substance use disorders --- prevalence --- primary major depression --- alcohol induced major depression --- biomarkers --- comorbidity --- clinical characteristics --- GWAS --- dual disorders (DD) --- insomnia --- sleep disorders (SD) --- benzodiazepine use disorder (BUD) --- health-related quality of life --- major depressive disorder --- dual depression --- relapses --- polysubstance addictions --- gene polymorphisms --- primary/substance-induced depression --- cocaine use disorder --- tryptophan --- serotonin --- kynurenine --- cannabis --- cannabis use disorder --- n/a
Choose an application
“Sex, Gender and Substance Use” describes how both biological and social factors affect people's use of substances. There is a lot of research carried out on substance use, prevention and treatment in which sex and gender are missing. This book describes the concepts of sex and gender, what they mean and why including them in substance use research, practice and policy is vital. Substances such as alcohol, drugs, nicotine, and tobacco all have differential effects on females and males. Social and cultural gendered factors affect how women and men react to prevention, treatment and policies. The book includes numerous examples of how sex- and gender-sensitive research can increase our understanding and improve prevention and treatment, and why striving for gender-transformative substance use practice and research remains a gold standard.
Humanities --- Social interaction --- alcohol --- pregnancy --- abortion --- policy --- gender --- substance use --- FASD prevention --- program evaluation --- multi-service program delivery --- client perspectives --- interpersonal violence --- domestic violence --- intervention --- women --- developmental–relational --- gender-specific approach --- non-medical prescription opioid use --- sleep disturbance --- sex differences --- adolescents --- sexual minorities --- illegal substance use --- homophobic bullying --- alcohol’s harms to others --- gender equality --- drinking cultures --- developmental-relational --- electronic cigarettes --- cigarettes --- waterpipe --- hookah --- polytobacco use --- young adults --- sex --- cognitions --- attitudes --- scoping review --- barriers --- facilitators --- fathers --- males --- smoking --- smoke-free home --- second-hand smoke --- brief intervention --- college campus --- gender transformative --- gender equity --- cannabis --- sex- and gender-based analysis --- SGBA --- cannabis use disorder --- randomized controlled trial --- gender norms --- gender roles --- gender relations --- technology --- health promotion --- SGBA+ --- substance use prevention --- tobacco --- smoking cessation --- clinical decision support systems --- prevention --- alcohol consumption --- FASD --- lifestyle --- public health --- Spain --- sex factors --- substance abuse --- drinking --- nicotine --- research
Choose an application
This book includes a compilation of papers published in 2020 and 2021 focused on dual disorders, which are found in significant and growing numbers in both substance addiction and mental health clinics. These contributions assume a broad perspective ranging from exposure to genetic and neurobiological elements to factors such as personality and quality of life. In all cases, these papers aimed to be transferred to and to benefit clinical practice.
temperament --- character --- personality --- substance use disorder --- schizophrenia --- dual schizophrenia --- psychiatric symptoms --- global functioning --- dual disorders --- addiction --- sleep --- risk factors --- Substance-use disorder --- substance-related disorders --- alcohol use disorder --- post-traumatic stress disorder --- childhood trauma --- psychiatric disorders --- rehabilitation centers --- impulsive behavior --- addictive disorders --- flaws --- conceptual framework --- concurrent disorder --- co-occurring disorder --- dual diagnosis --- dual pathology --- addiction comorbidity --- comorbid substance abuse --- comorbid illicit use --- comorbid addiction --- comorbid mental illness --- coexisting mental illness --- psychological trauma --- posttraumatic stress disorder --- substance use disorders --- prevalence --- primary major depression --- alcohol induced major depression --- biomarkers --- comorbidity --- clinical characteristics --- GWAS --- dual disorders (DD) --- insomnia --- sleep disorders (SD) --- benzodiazepine use disorder (BUD) --- health-related quality of life --- major depressive disorder --- dual depression --- relapses --- polysubstance addictions --- gene polymorphisms --- primary/substance-induced depression --- cocaine use disorder --- tryptophan --- serotonin --- kynurenine --- cannabis --- cannabis use disorder --- n/a
Choose an application
“Sex, Gender and Substance Use” describes how both biological and social factors affect people's use of substances. There is a lot of research carried out on substance use, prevention and treatment in which sex and gender are missing. This book describes the concepts of sex and gender, what they mean and why including them in substance use research, practice and policy is vital. Substances such as alcohol, drugs, nicotine, and tobacco all have differential effects on females and males. Social and cultural gendered factors affect how women and men react to prevention, treatment and policies. The book includes numerous examples of how sex- and gender-sensitive research can increase our understanding and improve prevention and treatment, and why striving for gender-transformative substance use practice and research remains a gold standard.
alcohol --- pregnancy --- abortion --- policy --- gender --- substance use --- FASD prevention --- program evaluation --- multi-service program delivery --- client perspectives --- interpersonal violence --- domestic violence --- intervention --- women --- developmental–relational --- gender-specific approach --- non-medical prescription opioid use --- sleep disturbance --- sex differences --- adolescents --- sexual minorities --- illegal substance use --- homophobic bullying --- alcohol’s harms to others --- gender equality --- drinking cultures --- developmental-relational --- electronic cigarettes --- cigarettes --- waterpipe --- hookah --- polytobacco use --- young adults --- sex --- cognitions --- attitudes --- scoping review --- barriers --- facilitators --- fathers --- males --- smoking --- smoke-free home --- second-hand smoke --- brief intervention --- college campus --- gender transformative --- gender equity --- cannabis --- sex- and gender-based analysis --- SGBA --- cannabis use disorder --- randomized controlled trial --- gender norms --- gender roles --- gender relations --- technology --- health promotion --- SGBA+ --- substance use prevention --- tobacco --- smoking cessation --- clinical decision support systems --- prevention --- alcohol consumption --- FASD --- lifestyle --- public health --- Spain --- sex factors --- substance abuse --- drinking --- nicotine --- research
Choose an application
“Sex, Gender and Substance Use” describes how both biological and social factors affect people's use of substances. There is a lot of research carried out on substance use, prevention and treatment in which sex and gender are missing. This book describes the concepts of sex and gender, what they mean and why including them in substance use research, practice and policy is vital. Substances such as alcohol, drugs, nicotine, and tobacco all have differential effects on females and males. Social and cultural gendered factors affect how women and men react to prevention, treatment and policies. The book includes numerous examples of how sex- and gender-sensitive research can increase our understanding and improve prevention and treatment, and why striving for gender-transformative substance use practice and research remains a gold standard.
Humanities --- Social interaction --- alcohol --- pregnancy --- abortion --- policy --- gender --- substance use --- FASD prevention --- program evaluation --- multi-service program delivery --- client perspectives --- interpersonal violence --- domestic violence --- intervention --- women --- developmental–relational --- gender-specific approach --- non-medical prescription opioid use --- sleep disturbance --- sex differences --- adolescents --- sexual minorities --- illegal substance use --- homophobic bullying --- alcohol’s harms to others --- gender equality --- drinking cultures --- developmental-relational --- electronic cigarettes --- cigarettes --- waterpipe --- hookah --- polytobacco use --- young adults --- sex --- cognitions --- attitudes --- scoping review --- barriers --- facilitators --- fathers --- males --- smoking --- smoke-free home --- second-hand smoke --- brief intervention --- college campus --- gender transformative --- gender equity --- cannabis --- sex- and gender-based analysis --- SGBA --- cannabis use disorder --- randomized controlled trial --- gender norms --- gender roles --- gender relations --- technology --- health promotion --- SGBA+ --- substance use prevention --- tobacco --- smoking cessation --- clinical decision support systems --- prevention --- alcohol consumption --- FASD --- lifestyle --- public health --- Spain --- sex factors --- substance abuse --- drinking --- nicotine --- research --- alcohol --- pregnancy --- abortion --- policy --- gender --- substance use --- FASD prevention --- program evaluation --- multi-service program delivery --- client perspectives --- interpersonal violence --- domestic violence --- intervention --- women --- developmental–relational --- gender-specific approach --- non-medical prescription opioid use --- sleep disturbance --- sex differences --- adolescents --- sexual minorities --- illegal substance use --- homophobic bullying --- alcohol’s harms to others --- gender equality --- drinking cultures --- developmental-relational --- electronic cigarettes --- cigarettes --- waterpipe --- hookah --- polytobacco use --- young adults --- sex --- cognitions --- attitudes --- scoping review --- barriers --- facilitators --- fathers --- males --- smoking --- smoke-free home --- second-hand smoke --- brief intervention --- college campus --- gender transformative --- gender equity --- cannabis --- sex- and gender-based analysis --- SGBA --- cannabis use disorder --- randomized controlled trial --- gender norms --- gender roles --- gender relations --- technology --- health promotion --- SGBA+ --- substance use prevention --- tobacco --- smoking cessation --- clinical decision support systems --- prevention --- alcohol consumption --- FASD --- lifestyle --- public health --- Spain --- sex factors --- substance abuse --- drinking --- nicotine --- research
Choose an application
This book includes a compilation of papers published in 2020 and 2021 focused on dual disorders, which are found in significant and growing numbers in both substance addiction and mental health clinics. These contributions assume a broad perspective ranging from exposure to genetic and neurobiological elements to factors such as personality and quality of life. In all cases, these papers aimed to be transferred to and to benefit clinical practice.
Medicine --- Mental health services --- temperament --- character --- personality --- substance use disorder --- schizophrenia --- dual schizophrenia --- psychiatric symptoms --- global functioning --- dual disorders --- addiction --- sleep --- risk factors --- Substance-use disorder --- substance-related disorders --- alcohol use disorder --- post-traumatic stress disorder --- childhood trauma --- psychiatric disorders --- rehabilitation centers --- impulsive behavior --- addictive disorders --- flaws --- conceptual framework --- concurrent disorder --- co-occurring disorder --- dual diagnosis --- dual pathology --- addiction comorbidity --- comorbid substance abuse --- comorbid illicit use --- comorbid addiction --- comorbid mental illness --- coexisting mental illness --- psychological trauma --- posttraumatic stress disorder --- substance use disorders --- prevalence --- primary major depression --- alcohol induced major depression --- biomarkers --- comorbidity --- clinical characteristics --- GWAS --- dual disorders (DD) --- insomnia --- sleep disorders (SD) --- benzodiazepine use disorder (BUD) --- health-related quality of life --- major depressive disorder --- dual depression --- relapses --- polysubstance addictions --- gene polymorphisms --- primary/substance-induced depression --- cocaine use disorder --- tryptophan --- serotonin --- kynurenine --- cannabis --- cannabis use disorder --- temperament --- character --- personality --- substance use disorder --- schizophrenia --- dual schizophrenia --- psychiatric symptoms --- global functioning --- dual disorders --- addiction --- sleep --- risk factors --- Substance-use disorder --- substance-related disorders --- alcohol use disorder --- post-traumatic stress disorder --- childhood trauma --- psychiatric disorders --- rehabilitation centers --- impulsive behavior --- addictive disorders --- flaws --- conceptual framework --- concurrent disorder --- co-occurring disorder --- dual diagnosis --- dual pathology --- addiction comorbidity --- comorbid substance abuse --- comorbid illicit use --- comorbid addiction --- comorbid mental illness --- coexisting mental illness --- psychological trauma --- posttraumatic stress disorder --- substance use disorders --- prevalence --- primary major depression --- alcohol induced major depression --- biomarkers --- comorbidity --- clinical characteristics --- GWAS --- dual disorders (DD) --- insomnia --- sleep disorders (SD) --- benzodiazepine use disorder (BUD) --- health-related quality of life --- major depressive disorder --- dual depression --- relapses --- polysubstance addictions --- gene polymorphisms --- primary/substance-induced depression --- cocaine use disorder --- tryptophan --- serotonin --- kynurenine --- cannabis --- cannabis use disorder
Listing 1 - 9 of 9 |
Sort by
|